AI
CMND icon

AdvisorShares Investments’s Clearmind Medicine CMND Stock Holding History

AdvisorShares Investments’s Portfolio CMND Stock Details CMND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.57K Buy
1,169
+433
+59% +$2.46K ﹤0.01% 265
2026
Q1 		$7.65K Buy
736
+73
+11% +$1.13K ﹤0.01% 276
2025
Q4 		$12K Buy
663
+102
+18% +$20.3K ﹤0.01% 288
2025
Q3 		$230K Buy
561
+46
+9% +$18.7K 0.04% 220
2025
Q2 		$182K Sell
515
-37
-7% -$14.2K 0.03% 223
2025
Q1 		$228K Buy
552
+132
+31% +$68.8K 0.04% 214
2024
Q4 		$232K Sell
420
-7
-2% -$3.88K 0.04% 217
2024
Q3 		$208K Buy
427
+105
+33% +$59.7K 0.04% 216
2024
Q2 		$214K Buy
322
+40
+14% +$19.3K 0.04% 221
2024
Q1 		$128K Buy
282
+50
+22% +$30.6K 0.02% 253
2023
Q4 		$260K Buy
232
+222
+2,220% +$349K 0.06% 221
2023
Q3 		$19.7K Hold
10
– – 0.01% 235
2023
Q2 		$57.9K Sell
10
-3
-23% -$20.3K 0.02% 242
2023
Q1 		$176K Buy
+13
New +$542K 0.06% 200

Other funds holding CMND

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

AdvisorShares Investments's CMND Position: Q2 2026 in Review

AdvisorShares Investments increased its Clearmind Medicine (CMND) stake by 59% in Q2 2026, buying an estimated $2.46K and bringing the position to 1,169 shares worth $2.57K. The position accounts for ﹤0.01% of the portfolio, ranked #265.

AdvisorShares Investments first reported a position in CMND in Q1 2023 and has held it in 14 quarters since. The position peaked at $260K in Q4 2023. 6 funds tracked by Wall St. Rank hold CMND as of Q2 2026.

  • AdvisorShares Investments held 1,169 shares of Clearmind Medicine worth $2.57K as of Q2 2026.
  • AdvisorShares Investments bought 433 Clearmind Medicine shares in Q2 2026, an estimated $2.46K.
  • Clearmind Medicine made up ﹤0.01% of AdvisorShares Investments's portfolio in Q2 2026, its #265 holding.
  • AdvisorShares Investments first reported a position in Clearmind Medicine in Q1 2023 and has held it in 14 quarters since.
  • AdvisorShares Investments's Clearmind Medicine position peaked at $260K in Q4 2023.
  • 6 funds tracked by Wall St. Rank held Clearmind Medicine as of Q2 2026.

Based on AdvisorShares Investments's 13F filing for Q2 2026, filed 11 Aug 2026.